Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-06 @ 1:34 PM
Study NCT ID:
NCT02652767
Status:
COMPLETED
Last Update Posted:
2022-07-29
First Post:
2016-01-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
Sponsor:
GenSight Biologics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Optic, Atrophy, Hereditary, Leber | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Leber Hereditary Optic Neuropathy | View |
| None | Leber Hereditary Optic Atrophy | View |
| None | Heredity Optic Atrophy | View |
| None | Eye Diseases | View |
| None | Hereditary Eye Diseases | View |
| None | Inborn Genetic Disease | View |
| None | Genetic Therapy | View |
| None | Intravitreal Injections | View |
| None | Mitochondrial Disease | View |
| None | AAV2 Vectors | View |
| None | Nervous System Diseases | View |
| None | Neurodegenerative Disease | View |
| None | Heredodegenerative Disorders of the Nervous System | View |